COX-2 inhibitor: Latest News, Top Stories & Analysis

Medical Products / Products and Services

Baudax Bio Announces U.S. Availability of ANJESO™ (meloxicam) Injection for the Management of Moderate to Severe Pain

MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that ANJESO™ (meloxicam) injection, the only 24-hour, intravenous (IV) COX-2 preferential …

Business / Health / Medical

Recro Pharma Announces Receipt of Issue Notifications for Three New Patents for IV Meloxicam

MALVERN, PA — Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, announced the receipt of issue notifications for three patents …